TAP
41
-2
ICE
66
2
AA
48
-3
EOG
47
-2
NEM
55
5
NEE
67
-3
KIM
61
-2
KSS
46
-4
COST
53
3
PRU
62
6
OKE
73
17
AMZN
60
-9
KEY
68
8
DD
38
-2
XOM
45
-5
TRV
56
4
ZBH
48
-6
HPQ
69
-2
ABBV
55
2
HPE
66
9
TAP
41
-2
ICE
66
2
AA
48
-3
EOG
47
-2
NEM
55
5
NEE
67
-3
KIM
61
-2
KSS
46
-4
COST
53
3
PRU
62
6
OKE
73
17
AMZN
60
-9
KEY
68
8
DD
38
-2
XOM
45
-5
TRV
56
4
ZBH
48
-6
HPQ
69
-2
ABBV
55
2
HPE
66
9
Financhill
Back

Cytokinetics 10K Form

Sell
12

CYTK
Cytokinetics

Last Price:
$31.01
Seasonality Move:
8.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10 10Q CYTK/Cytokinetics Quarterly
2023-11-03 10Q CYTK/Cytokinetics Quarterly
2023-08-03 10Q CYTK/Cytokinetics Quarterly
2023-05-05 10Q CYTK/Cytokinetics Quarterly
2022-11-04 10Q CYTK/Cytokinetics Quarterly
2022-08-05 10Q CYTK/Cytokinetics Quarterly

Receive CYTK News And Ratings

See the #1 stock for the next 7 days that we like better than CYTK

CYTK Financial Statistics

Sales & Book Value

Annual Sales: $18.5M
Cash Flow: $-137.3M
Price / Cash Flow: 0
Annual Sales: $-2.23
Price / Book: 61.87

Profitability

EPS (TTM): -5.29000
Net Income (TTM): $-615.3M
Gross Margin: $-320.9M
Return on Equity: 0%
Return on Assets: -47.82%

Cytokinetics Earnings Forecast

Key Cytokinetics Financial Ratios

  • The Gross Profit Margin over the past 20 years for CYTK is -1,737.22%.
  • The Selling, General & Administrative Expenses for CYTK have been equal to 1,165.50% of Gross Profit Margin.
  • The Research & Development expenses have been 227.10% of Revenue.
  • The Net Earning history of CYTK is -3,191.11% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 13 years.

Cytokinetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CYTK
CUSIP: 23282W
Website: cytokinetics.com

Debt

Debt-to-Equity Ratio: -2.47
Current Ratio: 5.99
Quick Ratio: 5.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CYTK Technical Analysis vs Fundamental Analysis

Sell
12
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Sell
    The current Cytokinetics [CYTK] share price is $30.75. The Score for CYTK is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.